Posts

Scientists use novel technique to create new energy-eff...

Breakthrough could help lead to the development of new low-power semiconductors ...

Preliminary clinical trial results show ‘dramatic and r...

A collaborative project to bring the promise of cell therapy to patients with a ...

New high-speed microscale 3D printing technique

3D-printed microscopic particles, so small that to the naked eye they look like ...

Water droplet spun by sound screens for colon cancer

DURHAM, N.C. – Mechanical engineers at Duke University have devised a new type o...

How to upcycle low-energy light

To combine two low-energy photons into one high-energy photon efficiently, the e...

First-of-its-kind super minigene to boost spinal muscul...

AMES, Iowa – Ravindra Singh has spent years studying a gene that when missing or...

Olympic tower construction at Teahupo’o, Tahiti could d...

In preparation for the 2024 Olympic surfing competition, a new judging tower is ...

UNH ingenuity offers unique way to track carbon emissio...

DURHAM, N.H. — Carbon dioxide (CO2) emissions are not typically associated with ...

STAT+: Here’s what you might have missed in Biden’s bud...

President Biden requests for the 2025 budget are potentially his last chance to ...

STAT+: For-profit health system’s Mass. hospitals teete...

For-profit health system Steward Health Care's Massachusetts hospitals are teete...

Delta 8 THC use reported by 11% of high school seniors

In the last year, an estimated 11% of high school seniors have used Delta 8 THC,...

STAT+: Researchers create talking throat patch for peop...

Researchers at the University of California, Los Angeles, have built a soft, adh...

STAT+: Pharmalittle: We’re reading about a failed schiz...

Acadia Pharmaceuticals disclosed that Nuplazid failed to improve the social and ...

When did Wall Street sour on Lilly’s Alzheimer’s drug?

Want to stay on top of the science and politics driving biotech today? Sign up t...

Opinion: No parent who has seen the children I’ve treat...

Pediatrician Paul Law fights measles in the Democratic Republic of Congo. He’s n...

STAT+: First medicine developed to treat MASH expected ...

The FDA is expected to approve the first medicine developed specifically to trea...